Paris, September 1, 2009 - Hybrigenics will provide expert protein interactions services to an American multinational life sciences company under a 3-year agreement. (read more...) |
|
Company receives EUR 400,000 of EU funding to screen inhibitors of protein interaction Paris- February 24th, 2009 - Hybrigenics will deploy its protein interaction expertise in the field of chronic inflammatory diseases. The company will develop a high throughput assay and screen its diverse 100,000 compound library and its collection of about 2,000 natural substances. |
|
|
Paris, July 1st, 2008 - Hybrigenics announced today that it has formed a strategic partnership to complement Hybrigenics' portfolio with Dualsystems' DUALmembrane yeast two-hybrid technology especially designed for full membrane proteins.Hybrigenics and Dualsystems will co-market DUALmembrane yeast two-hybrid screens. |
|
Paris, 13 December 2007 – Hybrigenics and L’Oréal are working together to know more about certain kin and hair proteins and to discover innovative substances: following the discovery of new interactions between skin proteins, a chemical screening has been carried out to identify small molecules able to inhibit one of these interactions, as part of L'Oréal's scientific research for innovative cosmetics.
|
|
Hybrigenics provides protein interaction screening and analysis tools for Genethon’s muscle cell program
2005 December - Hybrigenics, the pathway-based drug discovery company, today announces that Genethon, the gene and cell therapy research and application center, will use Hybrigenics’ Yeast Two-Hybrid Screening platform and its Protein Interaction Mapping software in a new program of research into muscle cell proteins and their interaction. The program will allow a better understanding of the muscle and the development of new therapeutic leads. |
|
|
|
